Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +45.17%
#2 Mubarak Mubarak +41.77%
#3 Pons Pons +38.24%
#4 Bitway Bitway +33.87%
#5 Starpower Starpower +30.66%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.20%
#7 TENDIES TENDIES +30.00%
#8 SkyAI SkyAI +24.19%
#9 Ocean Protocol Ocean Protocol +21.53%
#10 PondCoin PondCoin +19.51%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Classement en actions #29358
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Prix de l'action
$0.365
Dernière synchronisation: 2025-08-01
Capitalisation boursière
$21.54M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Elevation Oncology, Inc. (ELEV)

Catégorie

Healthcare
Ratio P/B pour Elevation Oncology, Inc. (ELEV)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Elevation Oncology, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Elevation Oncology, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH